# NUPLAZID
> **NDA210793** · New Drug Application · Sponsor: ACADIA PHARMS INC · Approved 2018-06-28
## Drug
- **FDA Application Number:** NDA210793
- **Application type:** New Drug Application
- **Brand name:** NUPLAZID
- **Generic name:** PIMAVANSERIN TARTRATE
- **Active ingredients:** PIMAVANSERIN TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACADIA PHARMS INC
- **Manufacturer:** Acadia Pharmaceuticals Inc.
- **First approval:** 2018-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210793)
---
*MORVS · CC0 1.0*